Committee Lens Health
— committee · oversees Health
Trades by this committee's members in the sector(s) it oversees — the committee's conflict surface — ranked by Conflict Score. How it's scored.
190
Flagged trades
17 / 33
Members trading in-jurisdiction
$2,747,595
Est. disclosed volume
75/100
Worst conflict score
Who's trading in-jurisdiction
Kevin Hern 40
Thomas Kean 28
John James 24
Lloyd Doggett 18
Greg Landsman 16
Carol Devine Miller 14
Debbie Dingell 12
Elizabeth Fletcher 7
Kelly Louise Morrison 7
Blake Moore 6
Dwight Evans 5
Michael Rulli 4
Kim Schrier 3
Mike Kelly 2
Linda Sanchez 2
Michael Fitzpatrick 1
Cliff Bentz 1
| Conflict | Member | Ticker | Company | Type | Date | Amount | Sector | Source |
|---|---|---|---|---|---|---|---|---|
| 75 | John James | JNJ | Johnson & Johnson | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | LLY | Eli Lilly & Co. | BUY | 2023-01-18 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | REGN | Regeneron Pharmaceuticals, Inc. | BUY | 2023-08-11 | $1K–$15K | Health | ↗ filing |
| 75 | John James | BMY | Bristol Myers Squibb Co. | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | ISRG | Intuitive Surgical Inc. | BUY | 2023-02-01 | $1K–$15K | Health | ↗ filing |
| 75 | John James | THC | Tenet Healthcare Corp. | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | SNY | Sanofi | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | NVO | Novo Nordisk A S | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | MRK | Merck & Co. Inc. | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | MDT | Medtronic plc | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | LH | Labcorp Holdings Inc. | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | BDX | Becton Dickinson & Co. | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | ABBV | Abbvie Inc. | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | John James | ABT | Abbott Laboratories | BUY | 2023-11-10 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | LLY | Eli Lilly & Co. | SELL | 2023-02-02 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | ISRG | Intuitive Surgical Inc. | BUY | 2023-05-04 | $1K–$15K | Health | ↗ filing |
| 75 | John James | BMY | Bristol Myers Squibb Co. | SELL | 2024-01-18 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | ISRG | Intuitive Surgical Inc. | BUY | 2023-05-30 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | LLY | Eli Lilly & Co. | BUY | 2023-05-11 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | ISRG | Intuitive Surgical Inc. | SELL | 2023-10-12 | $1K–$15K | Health | ↗ filing |
| 75 | John James | LH | Labcorp Holdings Inc. | SELL | 2024-03-06 | $1K–$15K | Health | ↗ filing |
| 75 | Greg Landsman | ISRG | Intuitive Surgical Inc. | SELL | 2023-08-02 | $1K–$15K | Health | ↗ filing |
| 74 | John James | MDT | Medtronic plc | SELL | 2024-06-03 | $1K–$15K | Health | ↗ filing |
| 72 | Elizabeth Fletcher | BDX | Becton Dickinson & Co. | SELL | 2019-02-07 | $1K–$15K | Health | ↗ filing |
| 71 | Greg Landsman | LLY | Eli Lilly & Co. | SELL | 2024-06-03 | $1K–$15K | Health | ↗ filing |
| 71 | John James | MDT | Medtronic plc | BUY | 2024-06-18 | $1K–$15K | Health | ↗ filing |
| 68 | Kevin Hern | BSX | Boston Scientific Corp. | BUY | 2021-07-01 | $100K–$250K | Health | ↗ filing |
| 68 | Elizabeth Fletcher | UHS | Universal Health Services Inc. | SELL | 2019-02-26 | $1K–$15K | Health | ↗ filing |
| 68 | Kevin Hern | MDT | Medtronic plc | SELL | 2021-12-20 | $100K–$250K | Health | ↗ filing |
| 68 | Elizabeth Fletcher | BDX | Becton Dickinson & Co. | SELL | 2019-02-26 | $1K–$15K | Health | ↗ filing |
| 67 | Carol Devine Miller | PFE | Pfizer Inc. | BUY | 2023-03-03 | $1K–$15K | Health | ↗ filing |
| 66 | Carol Devine Miller | JNJ | Johnson & Johnson | BUY | 2021-03-04 | $15K–$50K | Health | ↗ filing |
| 66 | Carol Devine Miller | PFE | Pfizer Inc. | SELL | 2025-03-10 | $15K–$50K | Health | ↗ filing |
| 66 | Carol Devine Miller | AMGN | Amgen Inc. | BUY | 2021-03-04 | $15K–$50K | Health | ↗ filing |
| 66 | Greg Landsman | LLY | Eli Lilly & Co. | SELL | 2024-11-08 | $15K–$50K | Health | ↗ filing |
| 66 | Carol Devine Miller | DGX | Quest Diagnostics Inc. | SELL | 2025-03-10 | $15K–$50K | Health | ↗ filing |
| 65 | Mike Kelly | EW | Edwards Lifesciences Corp. | SELL | 2024-04-11 | $1K–$15K | Health | ↗ filing |
| 65 | Greg Landsman | ISRG | Intuitive Surgical Inc. | SELL | 2024-07-17 | $15K–$50K | Health | ↗ filing |
| 65 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2024-03-05 | $1K–$15K | Health | ↗ filing |
| 64 | Thomas Kean | SYK | Stryker Corp. | SELL | 2023-01-10 | $15K–$50K | Health | ↗ filing |
| 64 | Carol Devine Miller | BMY | Bristol Myers Squibb Co. | SELL | 2021-11-10 | $15K–$50K | Health | ↗ filing |
| 64 | Carol Devine Miller | GILD | Gilead Sciences, Inc. | SELL | 2021-11-10 | $15K–$50K | Health | ↗ filing |
| 64 | Michael Fitzpatrick | LLY | Eli Lilly & Co. | BUY | 2014-08-07 | $1K–$15K | Health | ↗ filing |
| 64 | Carol Devine Miller | ABT | Abbott Laboratories | BUY | 2021-03-04 | $1K–$15K | Health | ↗ filing |
| 64 | Dwight Evans | AZN | Astrazeneca plc | BUY | 2016-12-30 | $1K–$15K | Health | ↗ filing |
| 64 | Kevin Hern | NVS | Novartis AG | SELL | 2026-08-27 | $15K–$50K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2023-03-08 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2022-06-07 | $1K–$15K | Health | ↗ filing |
| 64 | Dwight Evans | PFE | Pfizer Inc. | SELL | 2020-03-02 | $1K–$15K | Health | ↗ filing |
| 64 | Carol Devine Miller | PFE | Pfizer Inc. | SELL | 2025-03-10 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2023-09-07 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2023-12-05 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2022-12-07 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2026-09-08 | $1K–$15K | Health | ↗ filing |
| 64 | Carol Devine Miller | GILD | Gilead Sciences, Inc. | BUY | 2025-03-10 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2022-09-06 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2024-12-10 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2024-06-04 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2023-06-07 | $1K–$15K | Health | ↗ filing |
| 64 | Carol Devine Miller | DGX | Quest Diagnostics Inc. | SELL | 2025-03-10 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2025-03-04 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2026-06-09 | $1K–$15K | Health | ↗ filing |
| 64 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2024-09-10 | $1K–$15K | Health | ↗ filing |
| 63 | Mike Kelly | ABT | Abbott Laboratories | SELL | 2026-07-17 | $1K–$15K | Health | ↗ filing |
| 63 | Cliff Bentz | AMGN | Amgen Inc. | BUY | 2025-06-06 | $1K–$15K | Health | ↗ filing |
| 63 | Dwight Evans | PFE | Pfizer Inc. | BUY | 2018-08-17 | $1K–$15K | Health | ↗ filing |
| 63 | Kevin Hern | ALC | Alcon Inc. | SELL | 2026-08-05 | $1K–$15K | Health | ↗ filing |
| 63 | Kevin Hern | BSX | Boston Scientific Corp. | SELL | 2026-09-09 | $50K–$100K | Health | ↗ filing |
| 63 | Kevin Hern | BSX | Boston Scientific Corp. | SELL | 2026-09-04 | $50K–$100K | Health | ↗ filing |
| 63 | Thomas Kean | BDX | Becton Dickinson & Co. | BUY | 2024-01-11 | $1K–$15K | Health | ↗ filing |
| 63 | Thomas Kean | BDX | Becton Dickinson & Co. | BUY | 2025-05-13 | $1K–$15K | Health | ↗ filing |
| 63 | Thomas Kean | SYK | Stryker Corp. | SELL | 2025-11-20 | $15K–$50K | Health | ↗ filing |
| 63 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2026-03-10 | $1K–$15K | Health | ↗ filing |
| 63 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2025-12-09 | $1K–$15K | Health | ↗ filing |
| 63 | Greg Landsman | ISRG | Intuitive Surgical Inc. | SELL | 2024-07-17 | $1K–$15K | Health | ↗ filing |
| 63 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2025-06-10 | $1K–$15K | Health | ↗ filing |
| 62 | Lloyd Doggett | JNJ | Johnson & Johnson | BUY | 2019-06-12 | $1K–$15K | Health | ↗ filing |
| 62 | Carol Devine Miller | DGX | Quest Diagnostics Inc. | BUY | 2022-11-14 | $1K–$15K | Health | ↗ filing |
| 62 | Thomas Kean | ABT | Abbott Laboratories | BUY | 2024-12-16 | $1K–$15K | Health | ↗ filing |
| 61 | Kelly Louise Morrison | MRK | Merck & Co. Inc. | SELL | 2025-03-20 | $1K–$15K | Health | ↗ filing |
| 61 | Kevin Hern | NVO | Novo Nordisk A S | SELL | 2026-08-31 | $1K–$15K | Health | ↗ filing |
| 61 | Thomas Kean | SYK | Stryker Corp. | SELL | 2026-07-22 | $1K–$15K | Health | ↗ filing |
| 61 | Thomas Kean | JNJ | Johnson & Johnson | SELL | 2026-06-02 | $1K–$15K | Health | ↗ filing |
| 61 | Thomas Kean | SYK | Stryker Corp. | SELL | 2026-06-02 | $1K–$15K | Health | ↗ filing |
| 61 | Thomas Kean | SYK | Stryker Corp. | SELL | 2025-08-25 | $1K–$15K | Health | ↗ filing |
| 59 | Kevin Hern | STE | Steris plc | SELL | 2026-09-15 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | JNJ | Johnson & Johnson | SELL | 2023-01-27 | $15K–$50K | Health | ↗ filing |
| 59 | Carol Devine Miller | JNJ | Johnson & Johnson | BUY | 2020-07-28 | $15K–$50K | Health | ↗ filing |
| 59 | Debbie Dingell | PFE | Pfizer Inc. | BUY | 2016-02-23 | $15K–$50K | Health | ↗ filing |
| 59 | Debbie Dingell | AMGN | Amgen Inc. | BUY | 2016-02-23 | $15K–$50K | Health | ↗ filing |
| 59 | Carol Devine Miller | AMGN | Amgen Inc. | BUY | 2020-07-28 | $15K–$50K | Health | ↗ filing |
| 59 | Debbie Dingell | JNJ | Johnson & Johnson | BUY | 2016-02-18 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | JNJ | Johnson & Johnson | SELL | 2023-02-24 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | SYK | Stryker Corp. | SELL | 2023-01-27 | $15K–$50K | Health | ↗ filing |
| 59 | Debbie Dingell | JNJ | Johnson & Johnson | SELL | 2017-06-07 | $15K–$50K | Health | ↗ filing |
| 59 | Kevin Hern | MDT | Medtronic plc | BUY | 2021-07-01 | $15K–$50K | Health | ↗ filing |
| 59 | Kevin Hern | MDT | Medtronic plc | SELL | 2026-08-24 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | SYK | Stryker Corp. | SELL | 2023-02-24 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | JNJ | Johnson & Johnson | SELL | 2025-07-31 | $15K–$50K | Health | ↗ filing |
| 59 | Kevin Hern | BSX | Boston Scientific Corp. | SELL | 2025-10-28 | $15K–$50K | Health | ↗ filing |
| 59 | Kevin Hern | BDX | Becton Dickinson & Co. | SELL | 2026-03-17 | $15K–$50K | Health | ↗ filing |
| 59 | Kevin Hern | MDT | Medtronic plc | SELL | 2026-03-20 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | SYK | Stryker Corp. | SELL | 2025-07-31 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | SYK | Stryker Corp. | SELL | 2025-09-12 | $15K–$50K | Health | ↗ filing |
| 59 | Thomas Kean | SYK | Stryker Corp. | SELL | 2026-01-23 | $15K–$50K | Health | ↗ filing |
| 57 | Kelly Louise Morrison | JNJ | Johnson & Johnson | SELL | 2025-08-17 | $1K–$15K | Health | ↗ filing |
| 57 | Kelly Louise Morrison | RMD | Resmed Inc. | SELL | 2025-04-28 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | JNJ | Johnson & Johnson | BUY | 2020-07-27 | $1K–$15K | Health | ↗ filing |
| 57 | Blake Moore | JNJ | Johnson & Johnson | BUY | 2021-02-24 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | BDX | Becton Dickinson & Co. | BUY | 2020-04-09 | $1K–$15K | Health | ↗ filing |
| 57 | Michael Rulli | LLY | Eli Lilly & Co. | SELL | 2025-12-02 | $1K–$15K | Health | ↗ filing |
| 57 | Kelly Louise Morrison | RMD | Resmed Inc. | SELL | 2025-06-04 | $1K–$15K | Health | ↗ filing |
| 57 | Kelly Louise Morrison | RMD | Resmed Inc. | SELL | 2025-06-04 | $1K–$15K | Health | ↗ filing |
| 57 | Kelly Louise Morrison | RMD | Resmed Inc. | SELL | 2025-06-04 | $1K–$15K | Health | ↗ filing |
| 57 | Kelly Louise Morrison | RMD | Resmed Inc. | SELL | 2025-06-04 | $1K–$15K | Health | ↗ filing |
| 57 | Kim Schrier | BMY | Bristol Myers Squibb Co. | SELL | 2021-10-28 | $1K–$15K | Health | ↗ filing |
| 57 | Thomas Kean | ABT | Abbott Laboratories | BUY | 2024-07-23 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | NVS | Novartis AG | SELL | 2023-01-31 | $1K–$15K | Health | ↗ filing |
| 57 | Dwight Evans | ABBV | Abbvie Inc. | BUY | 2022-08-05 | $1K–$15K | Health | ↗ filing |
| 57 | Elizabeth Fletcher | MMM | 3M Co. | SELL | 2019-07-09 | $1K–$15K | Health | ↗ filing |
| 57 | Debbie Dingell | MDT | Medtronic plc | BUY | 2017-08-28 | $1K–$15K | Health | ↗ filing |
| 57 | Debbie Dingell | ABT | Abbott Laboratories | BUY | 2016-06-01 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | BIIB | Biogen Inc. | SELL | 2026-08-18 | $1K–$15K | Health | ↗ filing |
| 57 | Linda Sanchez | PFE | Pfizer Inc. | SELL | 2016-08-09 | $1K–$15K | Health | ↗ filing |
| 57 | Kim Schrier | BDX | Becton Dickinson & Co. | SELL | 2021-10-28 | $1K–$15K | Health | ↗ filing |
| 57 | Kim Schrier | ABT | Abbott Laboratories | SELL | 2021-10-28 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | BSX | Boston Scientific Corp. | BUY | 2021-05-20 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | MDT | Medtronic plc | BUY | 2019-11-07 | $1K–$15K | Health | ↗ filing |
| 57 | Debbie Dingell | ALC | Alcon Inc. | BUY | 2019-11-01 | $1K–$15K | Health | ↗ filing |
| 57 | Elizabeth Fletcher | ABT | Abbott Laboratories | SELL | 2019-07-09 | $1K–$15K | Health | ↗ filing |
| 57 | Debbie Dingell | NVS | Novartis AG | BUY | 2016-12-05 | $1K–$15K | Health | ↗ filing |
| 57 | Debbie Dingell | ABBV | Abbvie Inc. | BUY | 2016-06-22 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | OGN | Organon & Co. | SELL | 2026-08-05 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | OGN | Organon & Co. | SELL | 2026-08-05 | $1K–$15K | Health | ↗ filing |
| 57 | Greg Landsman | BMY | Bristol Myers Squibb Co. | SELL | 2025-03-27 | $1K–$15K | Health | ↗ filing |
| 57 | Elizabeth Fletcher | LLY | Eli Lilly & Co. | SELL | 2026-04-08 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | NVO | Novo Nordisk A S | SELL | 2026-09-10 | $1K–$15K | Health | ↗ filing |
| 57 | Greg Landsman | PFE | Pfizer Inc. | SELL | 2024-10-15 | $1K–$15K | Health | ↗ filing |
| 57 | Blake Moore | JNJ | Johnson & Johnson | BUY | 2021-02-25 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | JNJ | Johnson & Johnson | BUY | 2020-10-16 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | JNJ | Johnson & Johnson | BUY | 2023-03-07 | $1K–$15K | Health | ↗ filing |
| 57 | Michael Rulli | PFE | Pfizer Inc. | SELL | 2024-11-26 | $1K–$15K | Health | ↗ filing |
| 57 | Thomas Kean | JNJ | Johnson & Johnson | SELL | 2026-08-27 | $1K–$15K | Health | ↗ filing |
| 57 | Dwight Evans | ABBV | Abbvie Inc. | SELL | 2025-04-03 | $1K–$15K | Health | ↗ filing |
| 57 | Thomas Kean | JNJ | Johnson & Johnson | SELL | 2026-09-30 | $1K–$15K | Health | ↗ filing |
| 57 | Thomas Kean | SYK | Stryker Corp. | SELL | 2026-09-30 | $1K–$15K | Health | ↗ filing |
| 57 | Kevin Hern | JNJ | Johnson & Johnson | SELL | 2023-01-31 | $1K–$15K | Health | ↗ filing |
| 57 | Blake Moore | JNJ | Johnson & Johnson | BUY | 2021-03-26 | $1K–$15K | Health | ↗ filing |
| 57 | Thomas Kean | ABT | Abbott Laboratories | SELL | 2026-09-17 | $1K–$15K | Health | ↗ filing |
| 57 | Linda Sanchez | PFE | Pfizer Inc. | SELL | 2017-08-04 | $1K–$15K | Health | ↗ filing |
Showing the top 150 of 190 flagged trades by Conflict Score.